Research Article
Volume 11 Issue 1 - 2022
Exposure Risk and Clinical Characteristics of COVID-19 Patient Admitted into 3 Tertiary Hospitals in Northeastern Nigeria
Jacob A Dunga1*, Yarima Y Sulaiman2, Umar Dahuwa3, Yakubu Adamu4, Sabiu Gwalabe1, Jafiada J Musa1, Ballah Abubakar1, Auwal Abuabakar2, Calvin Chama1, Sati Awang2, Haruna U Liman1, Kefas P Zawaya5, Sulaiman Y Hamid6, Onwukeme C Obinna1, Shamaki Manzo1 and Yunana E Dickson1
1Abubakar Tafawa Balewa University Teaching Hospital Bauchi State, Nigeria
2Federal Medical Center Yola, Adamawa State, Nigeria
3Federal Medical Center Azare, Bauchi State, Nigeria
4United State Department of Defense Walter Reed Program, Abuja,Nigeria
5Federal Teaching Hospital Gombe, Nigeria
6State Specialist Hospital Bauchi, Nigeria
*Corresponding Author: Jacob A Dunga, Abubakar Tafawa Balewa University Teaching Hospital Bauchi State, Nigeria.
Received: November 23, 2021; Published: December 29, 2021




Abstract

Objectives: This study is aimed at determining the pattern of acquiring and clinical features of COVID-19 among patients admitted at the isolation centers tertiary hospitals in Nigeria. All patients who were confirmed COVID positive from February 2020 till January 2021 were considered for this study. All patients were tested using the RT-PCR. COVID-19 was confirmed by detecting SARS-CoV-2 RNA in throat swab samples. A total of 319 patients that met the criteria were used for this study, data on pattern of acquiring and mode of infection, clinical presentation and RT-PCR was obtained from the patient’s record.

Results: Of thee 319 patients there were more patients within 16-30 and 31 to 45 age bracket 90 (28%) and 79 (24.8) respectively,

History of recent travels within the last 14 days before diagnoses amongst cases was the highest identifiable risk factor among the study population 169 (46.9), this was followed by contact with undiagnosed symptomatic patients 81 (22.5%), History of contact with COVID-19 patients was also a significant risk amongst the study group 43 (11.9), a visit to crowded places like market and religious gathering (church/mosque) also carried a significant risk among the study group 30 (8.3%) and28 (7.8%) respectively, there was less risk associated with participation /or attending burial rite among the study group.

Fever 81(19.9%), cough 77(18.9%) and sore throat 40 (9.8%) were among the commonest presenting symptoms, other symptoms of Sneezing, sputum, rhinorrhea, diarrhoea, Anosmia, vomiting and ageusia were also seen at varying frequencies. There were 22% of cases with co-morbidity, the most common among which were Hypertension 43 (60.6%), diabetes 16(22.5%), chronic kidney disease 4 (5.6%), heart failure 3 (4.2%), Ischemic heart disease 2 (2.8%) and chronic diseases 3 (4.2%). Within 3 weeks of isolation 86.2% of patient had negative RT-PCR repeat test and 96% (306) had there symptoms resolved and a negative repeat RT-PCR at the end of the 6 weeks isolation period. There were 4.1% (13) mortality (p = 0.000).

Conclusion: History of recent travels within 14 days during outbreak of COVID-19, contact with asymptomatic COVID-19 patients were associated with increased risk of acquiring COVID-19.

Fever, cough and sore throat were among the commonest presenting symptoms, other symptoms of Sneezing, sputum, rhinorrhea, diarrhoea, Anosmia, vomiting and ageusia were also seen at varying frequencies.

Keyword: Exposure, Risk, clinical features, COVID-19

References

  1. World Health Organization (WHO)Novel corona virus (2020).
  2. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 10223 (2020): 497-506.
  3. Ma J China’s first confirm COVID-19 case traced back to 17 November 2019. South china morning post 19th March.
  4. Yu G., et al. "How early signs of the coronavirus were spotted, spread and throttled in China”. The Straits Times (2020).
  5. Naming the corona virus disease 9COVID-19) and the virus that causes it. www.who.int.
  6. Lu R., et al. “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding”. Lancet 10224 (2020): 565-574.
  7. Zhang L., et al. “Origin and evolution of the 2019 novel coronavirus. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America”. (2020).
  8. Ge XY., et al. “Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor”. Nature 503 (2013): 535-538.
  9. COVID-19 update (2021).
  10. Low ZY., et al. “SARS Coronavirus outbreak past and Pesent- a comparative analysis of SARS CoV-2 and its predecessors”. Virus Gene4 (2021): 307-331.
  11. WHO Director-General's opening remarks at the media briefing on COVID-19 - 3 (2020).
  12. Wong JEL., et al. “COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action”. JAMA: The Journal of the American Medical Association (2020).
  13. Chu CM., et al. “Initial viral load and the outcomes of SARS”. Canadian Medical Association Journal 171 (2004): 1349-1352.
  14. “Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance”. (2020).
  15. Ai T., et al. “Correlation of chest CT and RT-PCR Testing for coronavirus disease 2019 in china: A report of 1014 cases”. Radiology2 (2020): E32-E40.
  16. Bianchi I., et al. “The X chromosome and immune associated genes”. Journal of Autoimmunity2-3 (2012): J187-192.
  17. COVID-19 Sex-disaggregated data tracker. Global health 50/50 (2020).
  18. Klein SL and Flanagan KL. “Sex differences in immune responses”. Nature Reviews Immunology 10 (2016): 626-638.
  19. Steve A., et al. “The incubation period of coronavirus disease (COVID-19) From publicly confirmed cases: Estimation and application”. Annals of Internal Medicine (2020).
Citation: Jacob A Dunga., et al. “Exposure Risk and Clinical Characteristics of COVID-19 Patient Admitted into 3 Tertiary Hospitals in Northeastern Nigeria”. EC Pulmonology and Respiratory Medicine 11.1 (2022): 10-18.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


July Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the July issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before July 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.